-
Product Name
UPF1 Polyclonal Antibody
- Documents
-
Description
Polyclonal antibody to UPF1
-
Tested applications
WB, IHC
-
Species reactivity
Human, Mouse
-
Alternative names
UPF1 antibody; HUPF1 antibody; NORF1 antibody; RENT1 antibody; pNORF1 antibody; smg-2 antibody; UPF1, RNA helicase and ATPase antibody
-
Isotype
Rabbit IgG
-
Preparation
Antigen: A synthetic peptide corresponding to a sequence within amino acids 270-370 of human UPF1 (NP_002902.2).
-
Clonality
Polyclonal
-
Formulation
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
Storage instructions
Store at -20℃. Avoid freeze / thaw cycles.
-
Applications
WB 1:500 - 1:2000
IHC 1:50 - 1:200 -
Validations
Immunohistochemistry - UPF1 Polyclonal Antibody
Immunohistochemistry of paraffin-embedded human liver cancer using UPF1 antibody at dilution of 1:100 (40x lens).
Immunohistochemistry - UPF1 Polyclonal Antibody
Immunohistochemistry of paraffin-embedded mouse brain using UPF1 antibody at dilution of 1:100 (40x lens).
Immunohistochemistry - UPF1 Polyclonal Antibody
Immunohistochemistry of paraffin-embedded mouse heart using UPF1 antibody at dilution of 1:100 (40x lens).
-
Background
RNA-dependent helicase and ATPase required for nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Is recruited to mRNAs upon translation termination and undergoes a cycle of phosphorylation and dephosphorylation; its phosphorylation appears to be a key step in NMD. Recruited by release factors to stalled ribosomes together with the SMG1C protein kinase complex to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) (located 50-55 or more nucleotides downstream from the termination codon) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Phosphorylated UPF1 is recognized by EST1B/SMG5, SMG6 and SMG7 which are thought to provide a link to the mRNA degradation machinery involving exonucleolytic and endonucleolytic pathways, and to serve as adapters to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation and allowing the recycling of NMD factors. UPF1 can also activate NMD without UPF2 or UPF3, and in the absence of the NMD-enhancing downstream EJC indicative for alternative NMD pathways. Plays a role in replication-dependent histone mRNA degradation at the end of phase S; the function is independent of UPF2. For the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed. The ATPase activity of UPF1 is required for disassembly of mRNPs undergoing NMD. Essential for embryonic viability.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"